LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.81 | 84.90 | 1 | 9132 | 0.0001 | -0.4822 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.81 | 84.90 | 429 | 9132 | 0.0470 | 0.2713 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.81 | 84.90 | 2 | 9132 | 0.0002 | -0.4261 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 70.81 | 84.90 | 715 | 9132 | 0.0783 | 0.3713 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.52 | 84.90 | 1 | 9214 | 0.0001 | -0.4815 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.52 | 84.90 | 333 | 9214 | 0.0361 | 0.2240 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.52 | 84.90 | 8 | 9214 | 0.0009 | -0.2948 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 72.52 | 84.90 | 707 | 9214 | 0.0767 | 0.3681 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.22 | 84.90 | 1 | 9343 | 0.0001 | -0.4805 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.22 | 84.90 | 248 | 9343 | 0.0265 | 0.1712 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.22 | 84.90 | 1 | 9343 | 0.0001 | -0.4805 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 74.22 | 84.90 | 677 | 9343 | 0.0725 | 0.3582 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.93 | 84.90 | 1 | 8970 | 0.0001 | -0.4835 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.93 | 84.90 | 206 | 8970 | 0.0230 | 0.1409 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.93 | 84.90 | 1 | 8970 | 0.0001 | -0.4835 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 75.93 | 84.90 | 682 | 8970 | 0.0760 | 0.3633 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 77.64 | 84.90 | 1 | 9245 | 0.0001 | -0.4813 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 77.64 | 84.90 | 140 | 9245 | 0.0151 | 0.0767 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 77.64 | 84.90 | 4 | 9245 | 0.0004 | -0.3633 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 77.64 | 84.90 | 656 | 9245 | 0.0710 | 0.3528 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 79.34 | 84.90 | 1 | 9051 | 0.0001 | -0.4828 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 79.34 | 84.90 | 87 | 9051 | 0.0096 | 0.0036 | MN20160318_Q02 | F05 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 79.34 | 84.90 | 1 | 9051 | 0.0001 | -0.4828 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 79.34 | 84.90 | 612 | 9051 | 0.0676 | 0.3408 | MN20160318_Q02 | N03 |
| MCF 10A-H2B-mCherry | Dasatinib | 10 | 81.05 | 84.90 | 1 | 8863 | 0.0001 | -0.4843 | MN20160318_Q02 | F05 |